Security key
34960Q307
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 4,912,339
- Total 13F value
- $7,662,384
- Share change
- +94,794
- Put/Call ratio
- 265%
- SEC-reported price per share
- $1.56
- Number of holders
- 46
- Value change
- +$48,360
- Number of buys
- 21
- Number of sells
- 20
Open additional details 1 more signal available
Report period
Q1 2025
Institutions
46
Top holders
10
FBIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Fortress Biotech, Inc. SEC filings
Fortress Biotech, Inc. company facts
Fortress Biotech, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 34960Q307
Recent filing periods:
Ownership snapshot
Top reported holders of FBIO - Fortress Biotech, Inc. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cambridge Investment Rese...
Disclosed value leader
Cambridge Investment Rese...
Comparable rows
0/15
Latest evidence
31 Dec 2024
13F
3/4/5
Highest disclosed value: $1,872,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Cambridge Investment Research Advisors, Inc. has the largest disclosed position value at $1.87M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cambridge Investment Research Advisors, Inc.'s linked filing trail.
Disclosed position value
Top 5
Cambridge Investment Research Adv...
$1.87M
VANGUARD GROUP INC
$1.27M
PVG ASSET MANAGEMENT CORP
$782.2K
ENVESTNET ASSET MANAGEMENT INC
$485.2K
SHIKIAR ASSET MANAGEMENT INC
$477K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. |
13F
Company
|
—
class O/S missing
|
$1,872,000
924,307 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$1,265,734
625,054 shares
|
— | 31 Dec 2024 |
| PVG ASSET MANAGEMENT CORP |
13F
Company
|
—
class O/S missing
|
$782,248
386,295 shares
|
— | 31 Dec 2024 |
| ENVESTNET ASSET MANAGEMENT INC |
13F
Company
|
—
class O/S missing
|
$485,178
239,594 shares
|
— | 31 Dec 2024 |
| SHIKIAR ASSET MANAGEMENT INC |
13F
Company
|
—
class O/S missing
|
$477,000
235,969 shares
|
— | 31 Dec 2024 |
| Kestra Advisory Services, LLC |
13F
Company
|
—
class O/S missing
|
$458,118
226,231 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
46
Shares
4,912,339
Rows available
46
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
46
Q1 2025 holders
46
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend